Clinical Research Directory
Browse clinical research sites, groups, and studies.
Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cells for Tourette Syndrome
Sponsor: The Foundation for Orthopaedics and Regenerative Medicine
Summary
This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells for the treatment of Tourette Syndrome
Official title: Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Tourette Syndrome
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
0
Start Date
2022-01
Completion Date
2026-01
Last Updated
2026-10-16
Healthy Volunteers
No
Conditions
Interventions
Cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells
cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells